Stock Information | Gentian Share | Corporate Reporting
medical, diagnostics, immunoassays, assays, in vitro diagnostics, IVD products, avian antibodies, antibodies, clinical chemistry, diagnostic tests, biotechnology
15618
page-template,page-template-full_width,page-template-full_width-php,page,page-id-15618,page-child,parent-pageid-15340,bridge-core-1.0.6,ajax_fade,page_not_loaded,,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-18.2,qode-theme-bridge,wpb-js-composer js-comp-ver-6.0.5,vc_responsive
 

The Gentian Share

The Gentian Share

Find stock information and news about Gentian Diagnostics AS and the Gentian share at Oslo Børs where you find us under the ticker GENT-ME.

Shareholder structure

20 largest shareholders in Gentian Diagnostics AS as of 28.06.2019 according to VPS

ShareholderNo of Shares%
Holta Life Sciences AS 2 014 702 13,09 %
Vatne Equity AS 1 910 340 12,41 %
Safrino AS 1 300 000 8,44 %
Salix AS 1 132 040 7,35 %
Norron Sicav - Target 617 500 4,01 %
Vingulmork Predictor AS 535 710 3,48 %
Storebrand Vekst 493 864 3,21 %
Norda ASA 455 082 2,96 %
Portia AS 425 000 2,76 %
Statoil Pensjon 392 690 2,55 %
Verdipapirfondet DNB SMB 376 630 2,45 %
Silvercoin Industries AS 330 809 2,15 %
Bård Sundrehagen 307 010 1,99 %
Cressida AS 235 000 1,53 %
Marstal AS 202 500 1,32 %
Strawberry Capital AS 200 300 1,30 %
Spar Kapital Investor AS 192 291 1,25 %
Mutus AS 187 210 1,22 %
OM Holding AS 179 000 1,16 %
Lioness AS 150 000 0,97 %
Other Shareholders 3 758 243 24,41 %
Total Shares 15 395 921 100,00 %